CAR-T cell researchers optimistic about future of treating blood cancers

Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers.

Leave A Comment

Your email address will not be published. Required fields are marked *